Clinical Trials
Category Added in a WPeMatico Campaign
-
Effects of VIVIFRAIL intervention on multidimensional frailty in older nursing home residents: a randomised-controlled feasibility study
CONCLUSIONS: The VIVIFRAIL exercise program was determined to be feasible for older adults residing in nursing homes and significantly improved frailty status, health indicators, ADLs and QOL. These findings support the incorporation of structured exercise interventions as an essential component of routine care provided by health-care professionals in nursing home settings.
-
Clinical efficacy of abdominal moxibustion at the Zhongji (CV3) in combination with Yiqi Tonglin Yangyin decoction and antibiotics for treating elderly female patients with complicated urinary tract infection
CONCLUSION: Abdominal moxibustion at the Zhongji (CV3), combined with Yiqi Tonglin Yangyin decoction and antibiotics for treating complicated urinary tract infections in elderly women, can effectively improve the clinical symptoms, TCM syndromes, and immune function of patients. Additionally, it can reduce oxidative stress, promote patient recovery, and lower the recurrence rate with pronounced comprehensive efficacy.
-
First-in-Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of BIIB091, an Oral BTK Inhibitor, in Healthy Adult Participants
CONCLUSION: BIIB091 was well tolerated at single doses up to 1200 mg and repeated doses up to 300 mg BID, showing dose-linear PK and sustained effective B cell activation suppression. BIIB091 PK appeared to be sensitive to food effect. These important insights support its continued development for MS.
-
Impact of body mass index on the efficacy of acupuncture treatment of postprandial distress syndrome: secondary analysis of a randomized clinical trial
CONCLUSION: This subgroup analysis indicated that acupuncture improved PDS symptoms across different BMI categories. Acupuncture was suggested as a viable therapeutic option for patients with PDS, particularly those with a higher BMI.
-
Beneficial effects of Huanglian Jiedu decoction ( ) on metabolic syndrome: a prospective randomized controlled clinical trial
CONCLUSION: It can be concluded that HLJDD contributes to ameliorating metabolic disorders in individuals suffering from metabolic syndrome. The data also imply that the beneficial effects of HLJDD on metabolism might be attributed to its role in enhancing FGF-21 secretion, which is otherwise compromised due to metabolic inflammation.
-
Photobiomodulation in wounds of individuals with diabetes: a nonrandomized pilot study
CONCLUSION: Application of photobiomodulation at an intensity of 2 J/cm² once a week did not produce measurable changes in cytokine gene expression. However, significant reduction in wound area and improvement in tissue repair were observed in patients treated with photobiomodulation.
-
Does Oral Chromium Withstand Steroid Hyperglycemia in Postinterventional Ultrasound-guided Sacroiliac Joint Injections in Patients With Diabetes: A Double Blind Randomized Controlled Trial
CONCLUSIONS: Chromium supplementation improves glycemic control and reduces analgesic dependence in patients with diabetes who had an SIJ injection. Chromium supplementation therapy is a safe and cost-effective adjunct to standard diabetes management.
-
Bright IDEAS-YA Skills Training and Psychosocial Outcomes of Young Adults With Cancer: A Randomized Clinical Trial
CONCLUSIONS AND RELEVANCE: In this randomized clinical trial of Bright IDEAS-YA, intervention participants had significantly reduced distress and improved HRQOL relative to control. These findings suggest that Bright IDEAS-YA may be offered as supportive care for YAs with cancer to improve psychosocial outcomes.
-
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial
CONCLUSION: Based on this simulation model, using head-to-head SURMOUNT-5 trial data, tirzepatide (MTD) had lower total costs and higher QALYs compared to semaglutide (MTD). This supports that tirzepatide (MTD) is a cost-effective treatment option for individuals with obesity or overweight compared to semaglutide (MTD).
-
Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trial
Acquired pure red cell aplasia (aPRCA) is rare and challenging to treat. We investigated the efficacy and safety of sirolimus plus roxadustat in patients with aPRCA (Chinese Clinical Trial Register number, ChiCTR2200065107). We enrolled 82 patients with aPRCA in this prospective single-arm, open-label, multicenter trial between October 2022 and January 2024. Treatment response and safety…